Protective effect of ulinastatin on myocardial injuries in children with severe pneumonia.
American journal of translational research（2023）
Abstract
Ulinastatin has significant therapeutic efficacy and safety in the clinical treatment of children with severe pneumonia, which may be related to inhibition of the release of inflammatory factors, shortened QT dispersion and the improvement of immune function of peripheral blood T lymphocyte subsets.
MoreTranslated text
Key words
Myocardial injuries,T lymphocyte subsets,anti-infection,severe pneumonia,ulinastatin
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined